IL312808A - Sample infection detection of contaminated fragments for cancer classification - Google Patents

Sample infection detection of contaminated fragments for cancer classification

Info

Publication number
IL312808A
IL312808A IL312808A IL31280824A IL312808A IL 312808 A IL312808 A IL 312808A IL 312808 A IL312808 A IL 312808A IL 31280824 A IL31280824 A IL 31280824A IL 312808 A IL312808 A IL 312808A
Authority
IL
Israel
Prior art keywords
contamination detection
sample contamination
cancer classification
contaminated
fragments
Prior art date
Application number
IL312808A
Other languages
English (en)
Hebrew (he)
Inventor
Siddhartha Bagaria
Samuel S Gross
Original Assignee
Grail Llc
Siddhartha Bagaria
Samuel S Gross
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grail Llc, Siddhartha Bagaria, Samuel S Gross filed Critical Grail Llc
Publication of IL312808A publication Critical patent/IL312808A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20Supervised data analysis
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00Reactions characterised by treatment of reaction samples
    • C12Q2523/10Characterised by chemical treatment
    • C12Q2523/125Bisulfite(s)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/164Methylation detection other then bisulfite or methylation sensitive restriction endonucleases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/70Mechanisms involved in disease identification
    • G01N2800/7023(Hyper)proliferation
    • G01N2800/7028Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Data Mining & Analysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Primary Health Care (AREA)
  • Artificial Intelligence (AREA)
  • Bioethics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Evolutionary Computation (AREA)
  • Software Systems (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL312808A 2021-11-23 2022-11-23 Sample infection detection of contaminated fragments for cancer classification IL312808A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163282509P 2021-11-23 2021-11-23
PCT/US2022/080431 WO2023097278A1 (en) 2021-11-23 2022-11-23 Sample contamination detection of contaminated fragments for cancer classification

Publications (1)

Publication Number Publication Date
IL312808A true IL312808A (en) 2024-07-01

Family

ID=84830091

Family Applications (1)

Application Number Title Priority Date Filing Date
IL312808A IL312808A (en) 2021-11-23 2022-11-23 Sample infection detection of contaminated fragments for cancer classification

Country Status (10)

Country Link
US (1) US20230272477A1 (enExample)
EP (1) EP4437130A1 (enExample)
JP (1) JP2024544597A (enExample)
KR (1) KR20240103061A (enExample)
CN (1) CN118591638A (enExample)
AU (1) AU2022398491A1 (enExample)
CA (1) CA3237953A1 (enExample)
IL (1) IL312808A (enExample)
TW (1) TW202330933A (enExample)
WO (1) WO2023097278A1 (enExample)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3765637A1 (en) * 2018-03-13 2021-01-20 Grail, Inc. Anomalous fragment detection and classification
FI3625368T3 (fi) * 2018-08-08 2023-01-13 Menetelmiä john cunningham -viruksen aiheuttaman progressiivin multifokaalin leukoenkefalopatian kehittymisen riskin arviointiin geneettisellä testauksella
WO2020132572A1 (en) * 2018-12-21 2020-06-25 Grail, Inc. Source of origin deconvolution based on methylation fragments in cell-free-dna samples
CN119380810A (zh) * 2019-05-13 2025-01-28 格瑞尔有限责任公司 基于模型的特征化和分类
CN115461472A (zh) * 2020-03-30 2022-12-09 格里尔公司 使用合成添加训练样品进行癌症分类
JP2023520889A (ja) * 2020-03-31 2023-05-22 グレイル エルエルシー ゲノム領域モデリングによるがん分類
EP4413581A4 (en) * 2021-10-08 2025-11-05 Found Medicine Inc METHODS AND SYSTEMS FOR DETECTING AND ELIMINATING CONTAMINATION FOR A COPY NUMBER ALTERATION CALL

Also Published As

Publication number Publication date
KR20240103061A (ko) 2024-07-03
TW202330933A (zh) 2023-08-01
WO2023097278A1 (en) 2023-06-01
CN118591638A (zh) 2024-09-03
CA3237953A1 (en) 2023-06-01
JP2024544597A (ja) 2024-12-03
AU2022398491A1 (en) 2024-06-06
EP4437130A1 (en) 2024-10-02
US20230272477A1 (en) 2023-08-31

Similar Documents

Publication Publication Date Title
ES3066158T3 (en) Methods for screening biological samples for contamination
GB202106397D0 (en) Analysis of histopathology samples
EP4274907A4 (en) DEVICES AND METHODS FOR THE ANALYSIS OF BIOLOGICAL SAMPLES
EP3308155A4 (en) METHOD FOR THE ANALYSIS OF DETAILED AND CROSS CLASSIFICATION OF COMPLEX SAMPLES BY VACUUM UV SPECTROSCOPY AND GAS CHROMATOGRAPHY
SG11202101934SA (en) Methods and systems for sample processing or analysis
AU2021342788B2 (en) Multiple-sensor analysis of geological samples
EP3259069A4 (en) Classification of barcode tag conditions from top view sample tube images for laboratory automation
GB202213664D0 (en) Devices, methods and kits for biological sample capture and processing
EP4178610A4 (en) METHODS FOR DETECTION OF ANTIGENS FROM DIRECT CLINICAL SAMPLES
IL318593A (en) Identification of contamination samples of contaminated fragments with contamination markers
EP4034671A4 (en) COMPOSITION AND METHOD FOR IMPROVING THE DETECTION OF BIOMOLECULES IN BIOLOGICAL SAMPLES
EP3149475A4 (en) Method and apparatus for reducing carryover of reagents and samples in analytical testing
EP4288561A4 (en) SYSTEMS AND METHODS FOR THE ANALYSIS OF SAMPLES
GB202304590D0 (en) Compositions and methods for screening biological samples
GB2583901B (en) Apparatus and method for the automated detection of airborne biological particles
SG11202101403YA (en) Methods and systems for detecting contamination between samples
IL287180A (en) A method and system for classifying samples
GB202020375D0 (en) Wafer for carrying biological sample
EP4584578A4 (en) DEVICE AND METHOD FOR DETECTING SAMPLE CONTAMINATION
EP4109097A4 (en) BIOLOGICAL SAMPLE ANALYSIS PROCEDURE
EP4204577A4 (en) METHODS AND REAGENTS FOR THE RAPID DETECTION OF PATHOGENS IN BIOLOGICAL SAMPLES
CA223967S (en) Sample detector
GB2569329B (en) Apparatus for optical detection of contamination, radiation source, method for optical detection of contamination
GB202105577D0 (en) Analysis of histopathology samples
KR102674123B9 (ko) 검체 처리 장치